I-Mab Biopharma

Biotechnology Research

Overview

Industry

Biotechnology Research

Founded Year

2016

Company Type

Public Company

Website

http://www.i-mabbiopharma.com/

Social Media

Specialty

Antibody, Biologics, Biopharmaceutical, Bispecific antibodies, Cancer, Drug Development, Immuno-inflammation, Immuno-oncology, Monoclonal antibodies, Oncology, Pharmaceutical

Overview

I-Mab (NASDAQ: IMAB) is a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer. The Company’s differentiated pipeline is led by givastomig, a potential best-in-class, bispecific antibody read more company news read more company news read more company news read more company news...

Org Chart

Sign up to view details

Click to see org chart details

Headcount

Sign up to view details

Click to see headcount details

News

Sign up to view details

Click to see news details

Hirings

Sign up to view details

Click to see hirings details

FAQs

When was I-Mab Biopharma founded?

I-Mab Biopharma was founded in 2016.

What is I-Mab Biopharma's official website?

I-Mab Biopharma's official website is http://www.i-mabbiopharma.com/.

Find Contacts Everywhere

Find emails and phone numbers on LinkedIn, Company Websites and Your CRM!

Install Extension (It's Free)